GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Hyperinsulinemic, euglycemic clamp

Company
Vanderbilt University
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
11 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

11 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Hyperinsulinemic, euglycemic clamp and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02646475

    Metabolic Effects of Angiotensin-(1-7)

    Not yet reported Vanderbilt University 26 participants Est. completion 2029-12 1 site
    Other conditions: Obesity, Insulin Resistance, Hypertension, Metabolic Cardiovascular Syndrome
    View official trial listing →
  • Recruiting NCT NCT05010356

    Insulin Sensitivity After Breast Cancer

    Not yet reported University of Copenhagen 24 participants Est. completion 2026-09 1 site
    Other conditions: Insulin Sensitivity/Resistance, Breast Cancer, Survivorship, Metabolic Disturbance
    View official trial listing →
  • Recruiting NCT NCT05065372

    MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

    Not yet reported Kalie Tommerdahl 60 participants Est. completion 2027-07-31 2 sites
    Chronic kidney diseaseCardiovascular disease Other conditions: Type 1 Diabetes, Endothelial Dysfunction, Insulin Sensitivity
    View official trial listing →
  • Recruiting NCT NCT06042517

    Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

    Not yet reported Yale University 77 participants Est. completion 2027-09-30 1 site
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Recruiting NCT NCT06597851

    Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

    Not yet reported Azienda Ospedaliera Universitaria Integrata Verona 40 participants Est. completion 2026-06-30 1 site
    Other conditions: Coronary Microvascular Dysfunction, Coronary Microvascular Disease, Insulin Resistance
    View official trial listing →
  • Recruiting NCT NCT06609356

    Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

    Not yet reported Vanderbilt University Medical Center 27 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus, Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY), MODY2 Diabetes, Healthy Volunteer
    View official trial listing →
  • Recruiting NCT NCT06739473

    Total-body Glucose Utilization in Obesity

    Not yet reported Turku University Hospital 60 participants Est. completion 2024-12 1 site
    Other conditions: Obesity and Overweight
    View official trial listing →
  • Recruiting NCT NCT06776094

    Physical Activity and Insulin Sensitivity Dynamics

    Not yet reported University of Copenhagen 8 participants Est. completion 2027-01 1 site
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Recruiting NCT NCT06856291

    Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance

    ETH Zurich 40 participants Est. completion 2026-08-31 1 site
    Other conditions: Obesity and Obesity-related Medical Conditions, Obesity and Overweight, Insulin Sensitivity/Resistance, Semaglutide
    View official trial listing →
  • Recruiting NCT NCT07361874

    IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

    Not yet reported University of Texas Southwestern Medical Center 75 participants Est. completion 2030-05-31 1 site
    Other conditions: Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's, Mild Autonomous Cortisol Excess
    View official trial listing →
  • Recruiting NCT NCT07516509

    Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

    AdventHealth Translational Research Institute 36 participants Est. completion 2028-12 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00212160

    The Role of the Omentum in the Treatment of Morbid Obesity

    Not yet reported Vanderbilt University Medical Center 66 participants Est. completion 2011-10 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00282178

    Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

    Not yet reported Umeå University 26 participants Est. completion 2006-04 1 site
    Other conditions: Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00413335

    Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

    Not yet reported Yale University 21 participants Est. completion 2008-12 1 site
    PrediabetesType 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT00413348

    Type 2 Diabetes and the Effect of Probiotics

    Not yet reported Rigshospitalet, Denmark 48 participants Est. completion 2007-12 1 site
    Type 2 diabetes Other conditions: Healthy, Endotoxemia
    View official trial listing →
  • Withdrawn NCT NCT00536211

    Physical Inactivity and Insulin Resistance in Skeletal Muscle.

    Not yet reported University of Kansas Medical Center Est. completion 2011-12 1 site
    Metabolic syndrome Other conditions: Insulin Resistance, Hypertension, Hypercholesterolemia, Obesity
    View official trial listing →
  • Completed NCT NCT00551564

    Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

    Not yet reported GlaxoSmithKline 36 participants Est. completion 2008-09-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT00600730

    The Effects of Antecedent Hypoglycemia or Exercise on the Response of the Brain to Subsequent Hypoglycemia

    Not yet reported Vanderbilt University
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT00605774

    Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q5

    Not yet reported Vanderbilt University
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT00608816

    Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q4

    Not yet reported Vanderbilt University
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00780195

    Metabolic Adaptations to Diabetes in African Americans

    Not yet reported Vanderbilt University 16 participants Est. completion 2010-12
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00812591

    Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients

    Not yet reported Medical University of Graz 20 participants Est. completion 2011-03 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT00843791

    Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin

    Not yet reported Oregon Health and Science University 6 participants Est. completion 2011-05 1 site
    Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT00855244

    Metabolic Syndrome in Bone Marrow Transplant Survivors

    Not yet reported Nationwide Children's Hospital 5 participants Est. completion 2010-05 1 site
    Metabolic syndrome
    View official trial listing →
  • Withdrawn NCT NCT00946426

    Insulin Resistance in Type I Diabetes in Pediatric Care

    Nationwide Children's Hospital Est. completion 2010-05 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01115712

    Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)

    Not yet reported Merck Sharp & Dohme LLC 35 participants Est. completion 2010-09
    Other conditions: Healthy, Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT01116609

    Local Effects of Epinephrine on Lactate, Glucose, Lipid and Protein Metabolism in Bilaterally Perfused Human Legs

    Not yet reported University of Aarhus 10 participants Est. completion 2010-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01397279

    Assessment of Liver Glucose Metabolism in Diabetic Subjects

    Not yet reported German Diabetes Center 22 participants Est. completion 2013-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01400334

    Prediction of ARrhythmic Events With Positron Emission Tomography

    State University of New York at Buffalo 257 participants Est. completion 2012-12 1 site
    Other conditions: Ischemic Cardiomyopathy, Hibernating Myocardium, Nerve; Disorder, Sympathetic
    View official trial listing →
  • Completed NCT NCT01408667

    Hyperinsulinemic Euglycemic Clamp Protocol

    Not yet reported, Not yet reported Torrent Pharmaceuticals Limited 40 participants 1 site
    Other conditions: Metabolic Cardiovascular Syndrome
    View official trial listing →
  • Completed NCT NCT01433705

    Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers

    Not yet reported University of Michigan 70 participants Est. completion 2018-01-19 1 site
    Other conditions: Heart Disease
    View official trial listing →
  • Completed NCT NCT01467063

    Glutamine and Insulin Sensitivity in Type I Diabetes

    Not yet reported Nemours Children's Clinic 13 participants Est. completion 2013-07 1 site
    Other conditions: Type I Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01474785

    RYGB and the Gastric Adipose Axis

    Not yet reported Vanderbilt University 49 participants Est. completion 2015-07 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01482455

    Fat and Transcapillary Insulin Transport

    Not yet reported German Diabetes Center 8 participants Est. completion 2012-08 1 site
    Other conditions: Lipid-induced Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01571609

    Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders

    Not yet reported University of Aarhus 40 participants Est. completion 2014-11 1 site
    Metabolic syndrome Other conditions: Hyperlipidemia, Diabetes Mellitus, Arterial Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT01631370

    The Effects of Renal Denervation on Insulin Sensitivity

    Not yet reported University of Aarhus 8 participants Est. completion 2016-03-03 1 site
    Other conditions: Treatment Resistant Essential Hypertension, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01648478

    IRAPs (Secreted Insulin Regulated AminoPeptidase): a New Insulin Sensitivity Biomarker

    Not yet reported Hospices Civils de Lyon 21 participants Est. completion 2012-09 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT01660009

    Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans

    Not yet reported Medical College of Wisconsin 5 participants Est. completion 2017-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01680133

    Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes

    Maastricht University Medical Center 20 participants Est. completion 2011-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01833403

    Metabolomic Analysis of Hepatic Insulin Resistance

    Not yet reported University of Minnesota 4 participants Est. completion 2014-03 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02017210

    Insulin-sensitive Obesity: Lessons From Longitudinal Data

    Garvan Institute of Medical Research 57 participants Est. completion 2016-02 1 site
    Other conditions: Insulin Sensitivity/Resistance, Obesity
    View official trial listing →
  • Completed NCT NCT02077348

    Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.

    Not yet reported University of Aarhus 9 participants Est. completion 2015-09 1 site
    Other conditions: Diabetes Mellitus Type I, Ketoacidosis
    View official trial listing →
  • Status unknown NCT NCT02097342

    Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 30 participants Est. completion 2015-01 1 site
    Type 2 diabetes Other conditions: Insulin Sensitivity/Resistance
    View official trial listing →
  • Withdrawn NCT NCT02102243

    Neural Mechanism of Aldosterone-induced Insulin Resistance

    Not yet reported Wanpen Vongpatanasin Est. completion 2025-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02102737

    Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 40 participants Est. completion 2018-03 1 site
    Other conditions: Diabetes Mellitus, Insulin Resistance, Glucose Metabolism Disorders, Metabolic Diseases, Endocrine System Diseases
    View official trial listing →
  • Completed NCT NCT02233283

    Effect of Modifications of Nutritional Intake Upon Reproductive Hormones in Normal Women

    Not yet reported Centre Hospitalier Universitaire Vaudois 9 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Female Reproductive System Disorder
    View official trial listing →
  • Completed NCT NCT02517307

    Fatty Acid Oxidation Defects and Insulin Sensitivity

    Not yet reported Oregon Health and Science University 41 participants Est. completion 2021-03 1 site
    Other conditions: Very Long-chain Acyl-CoA Dehydrogenase Deficiency, Trifunctional Protein Deficiency, Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency, Medium-chain Acyl-CoA Dehydrogenase Deficiency, Normal Volunteers, Carnitine Palmitoyltransferase II Deficiency, Myopathic
    View official trial listing →
  • Active, not recruiting NCT NCT02653092

    Reprometabolic Syndrome Mediates Subfertility in Obesity

    Not yet reported University of Colorado, Denver 84 participants Est. completion 2026-12-11 1 site Stand-alone
    Other conditions: Obesity, Infertility, Hypogonadotropic Hypogonadotropism, Hyperinsulinemia
    View official trial listing →
  • Completed NCT NCT02706288

    Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health

    Not yet reported Washington University School of Medicine 8 participants Est. completion 2022-12 1 site
    Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02717832

    Protection Against Insulin Resistance in Obesity

    Not yet reported University of Michigan 26 participants Est. completion 2019-08-09 1 site
    Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT02722902

    Carnitine Infusion and Insulin Resistance

    Not yet reported Maastricht University Medical Center 17 participants Est. completion 2017-06 1 site
    Other conditions: Glucose Intolerance
    View official trial listing →
  • Completed NCT NCT02852759

    A Cold Physical Treatment to Manage Insulin Resistance

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 33 participants Est. completion 2019-08 1 site
    Other conditions: Insulin Resistance, Hyperglycemia, Hyperinsulinemia, Diabetes, Obesity
    View official trial listing →
  • Completed NCT NCT02933645

    Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity

    Not yet reported Turku University Hospital 10 participants Est. completion 2016-12 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02971202

    Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

    Not yet reported Vanderbilt University 33 participants Est. completion 2019-02 1 site
    Other conditions: Type 1 Diabetes Mellitus, Maturity-Onset Diabetes of the Young, Type 2, MODY2, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02987491

    Exercise and Insulin Signaling in Human Skeletal Muscle

    Not yet reported Oregon State University 20 participants Est. completion 2018-06-28 1 site
    Other conditions: Insulin Sensitivity, Obesity, Sedentary Lifestyle
    View official trial listing →
  • Completed NCT NCT03003793

    Insulin Sensitivity in Patients With Atopic Dermatitis

    University Hospital, Gentofte, Copenhagen 32 participants Est. completion 2017-12 1 site
    Type 2 diabetes Other conditions: Atopic Dermatitis/Eczema
    View official trial listing →
  • Completed NCT NCT03034226

    Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects

    Not yet reported University of Aarhus 18 participants Est. completion 2019-01-01 1 site
    Other conditions: Hypoglycemia, Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT03106688

    Neuromolecular Risk Factors for Obesity (PROSPECT)

    Not yet reported Turku University Hospital 60 participants Est. completion 2022-12-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03158363

    A New Model of Acute Febrile Disease

    Not yet reported University of Aarhus 6 participants Est. completion 2017-08-31 1 site
    Other conditions: Immobilization, Tonic, Fasting, Endotoxemia, Metabolism
    View official trial listing →
  • Completed NCT NCT03195400

    Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes

    Yale University 100 participants Est. completion 2022-08-12 1 site
    PrediabetesType 2 diabetes
    View official trial listing →
  • Completed NCT NCT03234751

    Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects

    Not yet reported AdventHealth Translational Research Institute 6 participants Est. completion 2020-02-19 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03461510

    Type 2 Diabetes and the Brain in Adolescents

    Not yet reported Nemours Children's Clinic 18 participants Est. completion 2019-01-30 1 site
    Type 2 diabetes Other conditions: Obesity, Pediatric Obesity, Insulin Resistance, Dysglycemia, Hyperglycemia
    View official trial listing →
  • Withdrawn NCT NCT03520153

    Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome

    Yale University Est. completion 2021-08 1 site
    Other conditions: McCune-Albright Syndrome, Fibrous Dysplasia, Intraductal Papillary Mucinous Neoplasm, Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT04028895

    Diagnostic Interest of the IRAP Protein (Insulin Regulated Amino Peptidase) in Insulin Resistance

    Not yet reported University Hospital, Grenoble 21 participants Est. completion 2022-06-30 4 sites
    Other conditions: Insulin Resistance Syndrome
    View official trial listing →
  • Completed NCT NCT04074668

    Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance

    University of Colorado, Denver 58 participants Est. completion 2022-11-15 1 site
    Chronic kidney disease Other conditions: Type 1 Diabetes, Diabetes, Diabetes Mellitus, Diabetes Complications, Diabetic Nephropathies, Type1diabetes, Diabetes, Autoimmune, Autoimmune Diabetes, Juvenile Diabetes, Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT04146909

    The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women

    Not yet reported Yale University 7 participants Est. completion 2022-11-28 1 site
    Other conditions: GDM, Lactation
    View official trial listing →
  • Completed NCT NCT04178603

    Copenhagen, Boston, Sydney

    Not yet reported University of Copenhagen 21 participants Est. completion 2020-09-01 1 site
    Type 2 diabetes Other conditions: Insulin Resistance, Insulin Sensitivity
    View official trial listing →
  • Completed NCT NCT04182464

    Effects of Sucralose in Insulin Sensitivity

    Not yet reported Paloma Almeda-Valdés 24 participants Est. completion 2021-10-30 1 site
    Other conditions: Insulin Sensitivity/Resistance
    View official trial listing →
  • Completed NCT NCT04272411

    SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism

    Not yet reported University Hospital Tuebingen 10 participants Est. completion 2020-06-01 1 site
    Other conditions: Spinal Cord Stimulation (SCS), Blood Glucose Metabolism, Euglycemic Hyperinsulinemic Clamp
    View official trial listing →
  • Completed NCT NCT04407481

    PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)

    University of Colorado, Denver 22 participants Est. completion 2022-10-13 1 site
    Other conditions: Polycystic Kidney Disease, Adult, Polycystic Kidney, Autosomal Dominant
    View official trial listing →
  • Active, not recruiting NCT NCT04754581

    Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes

    Not yet reported AdventHealth Translational Research Institute 39 participants Est. completion 2026-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT04759872

    Insulin and Muscle Fat Metabolism

    Not yet reported Oregon State University 9 participants Est. completion 2022-06-07 1 site
    Other conditions: Overweight and Obesity, Insulin Resistance, Metabolic Disease, Mitochondrial Metabolism, Sedentary Lifestyle
    View official trial listing →
  • Completed NCT NCT05110274

    Validating a Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber

    Not yet reported Pennington Biomedical Research Center 10 participants Est. completion 2022-07-08 1 site
    Other conditions: Metabolism
    View official trial listing →
  • Completed NCT NCT05355285

    Type 1 Diabetes and Depression: Role of Brain Glutamate

    Not yet reported Beth Israel Deaconess Medical Center 68 participants Est. completion 2014-11
    Other conditions: Type1diabetes, Depressive Symptoms, Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT05591235

    Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes

    Not yet reported Nanjing First Hospital, Nanjing Medical University 60 participants Est. completion 2023-02
    Other conditions: Type2diabetes, Insulin Resistance
    View official trial listing →
  • Active, not recruiting NCT NCT06105931

    Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

    Not yet reported Yale University 15 participants Est. completion 2027-08 1 site
    Other conditions: type1diabetes, Obesity
    View official trial listing →
  • Status unknown NCT NCT06116188

    Brain Insulin Resistance in Mild Cognitive Impairment

    Turku University Hospital 40 participants Est. completion 2025-10-10 1 site
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment, Positron Emission Tomography
    View official trial listing →
  • Completed NCT NCT06216665

    Effect of Pulsatile Hormone Administration on Insulin Action

    Not yet reported Pennington Biomedical Research Center 4 participants Est. completion 2024-05-09 1 site
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Completed NCT NCT06424652

    Effect of Physiologic Insulin Administration on Cognition

    Not yet reported Pennington Biomedical Research Center 1 participants Est. completion 2025-03-01 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07575438

    Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults

    Not yet reported May Faraj, PDt, PhD 84 participants Est. completion 2029-12 1 site
    Type 2 diabetesPrediabetes Other conditions: Obesity & Overweight
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.